Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Divestments (2019)

Historic Divestments for Avalo Therapeutics (AVTX) over the last 1 years, with Q4 2019 value amounting to $4.0 million.

  • Avalo Therapeutics' Divestments changed N/A to $4.0 million in Q4 2019 from the same period last year, while for Sep 2021 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $12.8 million for FY2020, which is 22429.67% up from last year.
  • Per Avalo Therapeutics' latest filing, its Divestments stood at $4.0 million for Q4 2019.
  • In the past 5 years, Avalo Therapeutics' Divestments ranged from a high of $4.0 million in Q4 2019 and a low of $4.0 million during Q4 2019